tirzepatide for the treatment of obstructive sleep apnea and obesity SURMOUNTs apnea, what's next in advancing GLP-1s? Trizepatide journal club presentation.ppt

If you find yourself not losing weight despite using GLP-1 medication, discussing your concerns with your healthcare provider is vital

L-

Thirty-eight percent of patients enrolled received allogeneic HCT (n=488), 48% of patients received autologous HCT (n=623), and 14% received chimeric antigen receptor T-cell therapy (n=188)

With a physical doctor they can be used safely for weight loss

But the goal is never as few as possible. Our providers recommend focusing on nutrient-rich foods and meeting your protein and fiber targets rather than counting calories to an exact figure

the goal is to reposition the deeper facial tissues to their anatomically correct locations and redrape the skin in harmony